C3.ai's Q1 Top Line Takes a Hit: Can Growth Reaccelerate in FY26?

C3.ai reported a 19% year-over-year revenue decline to $70.3 million in Q1, primarily due to softer demo license demand and leadership transitions, which has widened the FY26 loss per share estimate and contributed to a 27.6% stock decline. Despite this near-term pressure, the company noted strong partner-led customer momentum, significant enterprise wins, and a growing deployment pipeline, with management projecting modest sequential revenue improvement for Q2 and a path to stabilization in fiscal 2026. While the stock trades at a discount to the industry P/S, its earnings outlook remains significantly challenged.

Analysis

C3.ai, Inc. (AI) reported a weak start to fiscal 2026, with first-quarter revenue declining 19% year-over-year to $70.3 million, a result attributed to softer demand for demonstration licenses and internal disruption from leadership transitions. The top-line pressure was significant, evidenced by a $15.9 million sequential fall in demonstration license revenue, which was not offset by the $60.3 million in recurring subscription sales. This highlights a critical dependency on converting pilot programs into stable, long-term contracts. Despite these execution missteps, the company shows underlying operational momentum, with 90% of its 28 new deployments being partner-led through alliances with Microsoft Azure, AWS, and Google Cloud. However, the forward-looking picture remains cautious; second-quarter revenue guidance of $72-$80 million indicates only a modest sequential improvement. The stock's 27.6% decline over the past three months reflects severe market skepticism, which is further validated by a deteriorating earnings outlook. The Zacks Consensus Estimate for the fiscal 2026 loss per share has widened substantially from $0.37 to $1.33, with projections indicating a 224.4% year-over-year earnings decline, in stark contrast to the growth expected from industry peers.

Key Decisions for Investors

• Investors should exercise caution due to significant near-term execution risks, evidenced by the 19% year-over-year revenue decline, a projected 224.4% drop in fiscal 2026 earnings, and a consensus loss estimate that has widened to $1.33 per share.
• Monitor the company's ability to convert its growing pipeline of partner-led deployments into stable subscription revenue, as this is the primary catalyst required to offset the volatility and recent sharp decline in demonstration license sales.
• While the stock's forward price-to-sales multiple of 7.50 is below the industry average, its significant underperformance and higher valuation compared to specific, growing peers like Leidos and Vertiv suggest the discount may not be a compelling entry point without signs of fundamental stabilization.